Trustfeed Corp. licenses patent-pending IP from affiliate Pinata Holdings for drug delivery products

Polomar Health Services, Inc.

Royalty rates: 10% for metformin, 15% for sumatriptan/sildenafil, 20% for semaglutide/liraglutide on net sales.
License is worldwide, non-exclusive, perpetual; termination for material breach or 180 days notice.
Intended use is in products after planned acquisition of Polomar Specialty Pharmacy, announced June 28, 2024.
Pinata Holdings is an affiliate of CWR 1, LLC, the company's majority shareholder (related party transaction).
License covers patent-pending IP and know-how for delivery of five active ingredients (metformin, sumatriptan, semaglutide, liraglutide, sildenafil).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.